Analysts at Credit Suisse downgraded Infinity Pharmaceuticals INFI from “outperform” to “neutral.” The target price for Infinity Pharmaceuticals is set to $20. Infinity's shares closed at $13.31 yesterday.
Analysts at JMP Securities downgraded Progress Software PRGS from “market outperform” to “market perform.” Progress Software's shares closed at $25.60 yesterday.
RBC Capital downgraded Oracle ORCL from “outperform” to “sector perform.” The target price for Oracle is set to $35. Oracle's shares closed at $34.56 yesterday.
William Blair downgraded Brown & Brown BRO from “market perform” to “underperform.” Brown & Brown's shares closed at $30.26 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in